Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

BeOne Medicines Stock Price, Quotes and Forecasts | NASDAQ:ONC | Benzinga

Q: What sector and industry does BeOne Medicines (ONC) operate in?

BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore BeOne Medicines stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ONC.

Open	$256.47
Close	$247.07
Volume / Avg.	662.36K / 455.10K
Day Range	$245.52 - $256.52
52 Wk Range	172.67 - 287.88
Market Cap	$26.47B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.8%
Days to Cover	4.39

Recent News

China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1-positive patients.

Vandana Singh

Alibaba, Super Micro Computer And XPeng Are Among Top 10 Large Cap Gainers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?

Top performing large-cap stocks in the last week: Unity, Super Micro Computer, Alibaba, FTAI Aviation, STMicroelectronics, XPeng, Analog Devices, BeiGene, Tencent Music, Microchip Technology.

Lekha Gupta

Leap Therapeutics Halts Sirexatamab Combo Therapy For Gastric Cancer ON Unclear Positive Signal, Stock Crashes

Leap Therapeutics' Phase 2 data shows sirexatamab improves ORR in colorectal cancer. Gastric cancer studies end due to lack of PFS benefit.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.8

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$256.47
Close	$247.07
Volume / Avg.	662.36K / 455.10K
Day Range	$245.52 - $256.52
52 Wk Range	172.67 - 287.88
Market Cap	$26.47B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.8%
Days to Cover	4.39

About BeOne Medicines Ltd

Sector

Health Care

Industry

Biotechnology

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commerc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeOne Medicines (ONC) stock?

You can purchase shares of BeOne Medicines (NASDAQ:ONC) through any online brokerage.

View our list of the best stock brokerages

Who are BeOne Medicines (ONC) competitors?

Other companies in BeOne Medicines’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for BeOne Medicines (ONC) stock?

BeOne Medicines has a consensus price target of $330.50.

What is the current price for BeOne Medicines (ONC)?

The stock price for BeOne Medicines (NASDAQ: ONC) is $247.07 last updated March 7, 2025 at 4:00 PM EST.

Does BeOne Medicines (ONC) pay a dividend?

There are no upcoming dividends for BeOne Medicines.

When is BeOne Medicines (NASDAQ:ONC) reporting earnings?

BeOne Medicines’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is BeOne Medicines (ONC) going to split?

There is no upcoming split for BeOne Medicines.

What sector and industry does BeOne Medicines (ONC) operate in?

BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BeOne Medicines Stock Price, Quotes and Forecasts

BeOne Medicines (ONC) Forecast